March 2024
172 articles-
Mar 28 · 23:25Biotechnology Daily
Galecto posts myelofibrosis data as search for savior continues, investors shrug
-
Mar 28 · 23:24Biotechnology Daily
Jazz drops PTSD drug over phase 2 trial failure
-
Mar 28 · 23:23Biotechnology Daily
Equillium swaps multi-cytokine inhibitor for oral option after underwhelming phase 2 data
-
Mar 28 · 23:22Biotechnology Daily
FDA approves first genetic test to screen for opioid use disorder risks
-
Mar 28 · 23:21Bio Business News
AbbVie frees Alpine from climbing trial costs, agreeing to end study early in return for reduced fees
-
Mar 28 · 23:20Bio Business News
Philips faces Class I recall for MRI machines at risk of explosion
-
Mar 28 · 23:19Bio Business News
After DOJ indictment, SEC joins in on fraud accusations against Stimwave ex-CEO
-
Mar 28 · 23:18Bio Business News
MeiraGTx gifts remaining gene therapy rights to J&J for up to $415M
-
Mar 28 · 05:50Biotechnology Daily
FDA unconvinced by Clene’s request for ALS therapy’s accelerated approval tag
-
Mar 28 · 05:45Biotechnology Daily
Immunovant stakes claim for FcRn niche, posting midphase Graves’ data and plotting next steps
-
Mar 28 · 05:44Biotechnology Daily
ZyVersa taps George Clinical to run kidney disease trial
-
Mar 28 · 05:42Biotechnology Daily
Sanofi’s oncology strategy suffers another blow as ADC scrapped over phase 3 lung cancer fail
-
Mar 28 · 05:41Bio Business News
Merck, with GSK in its rearview, suffers second FDA rejection of cough drug gefapixant
-
Mar 28 · 05:39Bio Business News
Takeda’s gene therapy pivot leaves JCR behind after proof-of-concept preclinical test
-
Mar 28 · 05:37Bio Business News
Barinthus' new mission gets $35M booster from CEPI funding to develop MERS shot
-
Mar 28 · 05:36Bio Business News
Lilly tames Fauna to go on the prowl for obesity targets in $494M deal
-
Mar 27 · 01:21Biotechnology Daily
‘Explainable’ AI discovers new class of antibiotics that stop MRSA in mice
-
Mar 27 · 01:19Biotechnology Daily
Passage looks to offload lead program, 2 other clinical-stage assets
-
Mar 27 · 01:18Biotechnology Daily
CRISPR Therapeutics' CMO resigns 6 days after Casgevy's FDA approval
-
Mar 27 · 01:16Biotechnology Daily
Masimo nabs FDA nod for health-tracking baby monitor system
-
Mar 27 · 01:14Bio Business News
Medtronic faces another Class I recall of its StealthStation surgical navigation software
-
Mar 27 · 01:10Bio Business News
Olympus lung scope recall details risks of fires, internal burns
-
Mar 27 · 01:07Bio Business News
Clemson University unit teams up with CRO Precia to reach out to underserved rural communities
-
Mar 27 · 01:04Bio Business News
GSK heads back to Hansoh, paying $185M upfront for another ADC